In modern biopharmaceutical formulation, sterile active pharmaceutical ingredient (API) synthesis, and cell culture laboratories, water is not merely a utility—it is a critical process reagent. Achieving and maintaining ASTM Type I and USP Water for Injection (WFI) resistivity of 18.2 MΩ·cm while strictly eliminating microbiological contamination has historically posed a significant engineering hurdle.
1. The Traditional Dilemma: Chemical Mixed-Bed vs. Biofilm Contamination
Conventional high-purity water generation relied heavily on ion exchange mixed-bed resin columns. While effective at producing high initial resistivity, traditional mixed-beds present severe operational liabilities for regulated life-sciences facilities:
- Chemical Hazards: Regeneration requires hazardous handling of concentrated hydrochloric acid (HCl) and sodium hydroxide (NaOH), incurring substantial neutralization and regulatory compliance costs.
- Microbial Proliferation: Stagnant resin beds operate at ambient temperatures, acting as fertile breeding grounds for pseudomonas and gram-negative bacterial biofilms, causing sudden endotoxin spikes above the USP 0.25 EU/ml threshold.
- Costly Downtime: Chemical regeneration cycles force entire pilot facilities into hours of unplanned production interruption.
2. The Engineering Solution: Hot-Water Sanitizable CEDI Stacks
Continuous Electrodeionization (CEDI) replaces chemical regeneration with a continuous direct current (DC) electric field. Water molecules are continuously split into H+ and OH- ions within the concentrate chamber, regenerating ion-exchange resin beads in-situ during active water production.
To resolve microbial biofilm risks, JIMMI engineers process-grade CEDI stacks utilizing specialty heat-tolerant ion-exchange membranes, robust polysulfone (PSF) spacers, and sanitary electropolished 316L hardware capable of withstanding periodic 85°C thermal sanitization without module disassembly.
Validated Laboratory Benchmark: U.S. Life-Sciences Facility
In a benchmark pilot installation supervised by senior analytical researchers (including Dr. PJ LaRive / TM Biotech research group in the United States), JIMMI’s compact CEDI stack was integrated downstream of a two-pass reverse osmosis skid. Over a continuous 90-day evaluation, the module demonstrated:
- Consistent Resistivity: 18.2 MΩ·cm at 25°C across variable feed conductivities.
- Silica Rejection: > 96.5% reactive silica reduction, protecting downstream autoclave boilers.
- Zero Chemical Downtime: Weekly 85°C thermal sanitization protocols maintained total viable bacteria count below 10 CFU/100ml without toxic biocide flushes.
3. Technical Specifications & Sourcing Parameters
JIMMI provides factory-calibrated CEDI modules ranging from laboratory scale (30–200 L/H) to industrial production units (500 L/H to 5,000 L/H):
Need an Engineered CEDI Datasheet or System P&ID?
Contact our senior fluid engineers directly for pilot equipment sizing, 3D CAD models, or custom skid configurations.
Request CEDI Technical Proposal →